The EpiFinder device from Israel’s Omeq Medical (see here previously) has just received US FDA approval. A limited US launch is planned for early 2024. https://www.israel21c.org/smart-device-aims-to-improve-safety-of-epidurals/

I reported previously (Aug 2013) on Israel’s Omeq Medical and its smart sensor-based epidural injection system.  Omeq has partnered with Shanghai-based Pharos Medical, which will establish a production line and commercialize Omeq’s system in China. https://www.trendlines.com/omeq-medical-raises-3-million-and-signs-commercialization-agreement/

The method of applying epidural injections hasn’t changed for 100 years. The skill of the doctor is vital with high failure rates (30%) and frequent complications. But Israel’s Omeq Medical’s sensor-based system guides the doctor to the exact spot. Over … Continue reading →